Celularity Inc. CELU
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -58.14% | -62.78% | -51.03% | -15.81% | 4.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -58.14% | -62.78% | -51.03% | -15.81% | 4.45% |
| Cost of Revenue | -24.70% | 6.32% | 33.92% | 16.16% | 17.96% |
| Gross Profit | -85.39% | -97.07% | -83.49% | -33.64% | -4.46% |
| SG&A Expenses | -30.81% | -21.58% | -12.58% | -6.10% | 3.45% |
| Depreciation & Amortization | -129.24% | -126.54% | -123.84% | -25.34% | -29.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.12% | -15.78% | -7.36% | 1.28% | 5.21% |
| Operating Income | -0.14% | -41.72% | -54.07% | -21.91% | -5.94% |
| Income Before Tax | 37.76% | -27.77% | -58.42% | -130.14% | 34.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.75% | -27.78% | -58.43% | -130.08% | 34.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.75% | -27.78% | -58.43% | -130.08% | 34.71% |
| EBIT | -0.14% | -41.72% | -54.07% | -21.91% | -5.94% |
| EBITDA | -3.13% | -54.12% | -71.77% | -30.94% | -11.16% |
| EPS Basic | 46.96% | -10.73% | -35.65% | -113.99% | 45.07% |
| Normalized Basic EPS | 49.11% | -12.31% | -26.44% | -133.87% | -121.93% |
| EPS Diluted | 46.86% | -10.86% | -35.65% | -113.99% | 45.07% |
| Normalized Diluted EPS | 49.06% | -12.38% | -26.44% | -133.87% | -121.93% |
| Average Basic Shares Outstanding | 23.30% | 20.35% | 16.90% | 13.89% | 12.92% |
| Average Diluted Shares Outstanding | 24.64% | 21.72% | 16.90% | 13.89% | 12.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |